Improved outcomes with allogeneic compared with autologous stem cell transplantation in aggressive T‐cell lymphoma
- Resource Type
- Authors
- Ali Gondal; Graham McIlroy; Behrad Barmayehvar; Sridhar Chaganti; Lindsay George; Ram Malladi; Sivesh K. Kamarajah
- Source
- European Journal of Haematology. 105:514-516
- Subject
- business.industry
medicine.medical_treatment
Hematopoietic Stem Cell Transplantation
Refractory Disease
Disease Management
Hematology
General Medicine
Newly diagnosed
Hematopoietic stem cell transplantation
Lymphoma, T-Cell
medicine.disease
Transplantation, Autologous
Lymphoma
Treatment Outcome
Autologous stem-cell transplantation
T-Cell Non-Hodgkin Lymphoma
immune system diseases
hemic and lymphatic diseases
medicine
Cancer research
Humans
Transplantation, Homologous
T-cell lymphoma
business
- Language
- ISSN
- 1600-0609
0902-4441
Peripheral T-cell lymphomas (PTCL) are a rare and aggressive subtype of non-Hodgkin lymphoma (NHL), comprising up to 10% of all newly diagnosed NHL in the UK. The use of hematopoietic stem cell transplantation (SCT) to improve survival is has gained recognition in the up-front and relapsed setting, although evidence is limited for patients with refractory disease.